Cooper Cos.

Cooper Companies is a global medical device company. The company operates through two business units, CooperVision and CooperSurgical. CooperVision develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring materials and optics. CooperVision markets single-use silicone hydrogel with a line of spherical, toric and multifocal lenses under its clariti? 1day brand and single-use silicone hydrogel spherical and toric lenses under its MyDay? brand. CooperSurgical's business operates in the general health care market with a focus on improving the health of women, babies and families through a portfolio of products and services including medical devices.
  • TickerCOO
  • ISINUS2166484020
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Cooper Companies Inc: 2 directors bought

Two Directors at Cooper Companies Inc bought 1,889 shares at between 278.230USD and 280.117USD. The significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under list...

Valens Research

Valens Equity Insights and Inflections - 2020 06 23

AMKR currently trades at a discount to Uniform assets, with a 0.6x Uniform P/B (V/A'). At these levels, the market is pricing in expectations for Uniform ROA to improve from immaterial levels in 2019 to just 3% through 2024, accompanied by 4% Uniform asset growth going forward. Meanwhile, analysts have similarly muted expectations, projecting Uniform ROA to expand to 3% by 2021, accompanied by 2% Uniform asset shrinkage. That said, management is excited about their cost reduction actions and confident about their long-term growth strategy. Current valuations appear to be pricing in overly bear...

Valens Research

COO - Embedded Expectations Analysis - 2020 06 16

The Cooper Companies, Inc. (COO:USA) currently trades above recent averages relative to UAFRS-based (Uniform) earnings, with a 28.1x Uniform P/E. At these levels, the market has bullish expectations for the firm, but management may be concerned about MiSight sales growth, pricing pressures, and product launches Specifically, management may have concerns about MyDay lens capacity constraints,the ability of the EMEA region to recover, and the sales impact of coronavirus, namely in South Korea. In addition, they may lack confidence in their ability to sustain CooperVision gross margin and MiSigh...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Restaurant names are staging price and RS reversals or continue to have bullish formations. (ex. CHUY, JACK, CMG) • There are a few healthcare related names that continue to be bright spots and reflect leadership. (ex. CUTR, TFX, BSX, SYK, ADUS, CHE, COO, WST, TRHC, HUM, AMGN, PBH, MRK, and ZTS.) • REITs continue to show leadership characteristics' as many are hitting price and RS highs. (ex. OHI, SBRA, ESS, IRT, and MAA)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Gold appears to be developing a potential head-and-shoulders bottom. A break above the $128 level would be very bullish. (ex. GLD and GDX) • A number of restaurants are bullishly inflecting, trending up and to the right. (ex. JACK, DIN, SHAK, and YUM) • REIT's continue to be leadership (ex. PSB, HCP, HR, WELL, ARE, ESS, MAA, AMT, CCI, and SBAC)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders and Auto Parts suppliers continue to stage price and RS reversals. • A number of Industrial Manufacturing are in the process of reversing price and RS downtrends or forming bullish bases. • Semiconductors and Semi-Suppliers continue to be leadership with many breaking topside of bases and staging price and RS reversals.

Cooper Companies Inc: 2 directors bought

Two Directors at Cooper Companies Inc bought 1,889 shares at between 278.230USD and 280.117USD. The significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under list...

Valens Research

Valens Equity Insights and Inflections - 2020 06 23

AMKR currently trades at a discount to Uniform assets, with a 0.6x Uniform P/B (V/A'). At these levels, the market is pricing in expectations for Uniform ROA to improve from immaterial levels in 2019 to just 3% through 2024, accompanied by 4% Uniform asset growth going forward. Meanwhile, analysts have similarly muted expectations, projecting Uniform ROA to expand to 3% by 2021, accompanied by 2% Uniform asset shrinkage. That said, management is excited about their cost reduction actions and confident about their long-term growth strategy. Current valuations appear to be pricing in overly bear...

Valens Research

COO - Embedded Expectations Analysis - 2020 06 16

The Cooper Companies, Inc. (COO:USA) currently trades above recent averages relative to UAFRS-based (Uniform) earnings, with a 28.1x Uniform P/E. At these levels, the market has bullish expectations for the firm, but management may be concerned about MiSight sales growth, pricing pressures, and product launches Specifically, management may have concerns about MyDay lens capacity constraints,the ability of the EMEA region to recover, and the sales impact of coronavirus, namely in South Korea. In addition, they may lack confidence in their ability to sustain CooperVision gross margin and MiSigh...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior